 |
|
| CLINICAL HEMATOLOGY AND ONCOLOGY
| |
| | |
|
|
Presentation, Diagnosis and Treatment
To order this title, and for more information, click here
By
Bruce Furie, MD, Professor of Medicine, Harvard Medical School; Chief, Division of Hemostasis and Thrombosis, Department of Medicine, Beth Israel Deaconess Medical Center, Boston, MA
Michael Atkins, MD, Associate Professor of Medicine, Harvard Medical School; Director of Clinical Cancer Research, Beth Israel Deaconess Medical Center, Boston, MA
Robert Mayer, MD, Professor of Medicine, Harvard Medical School, Vice Chair for Academic Affairs, Department of Medical Oncology, Dana-Farber Cancer Center, Boston, MA
Peter Cassileth, MD, Professor of Medicine, University of Miami Sylvester Comprehensive Cancer Center, Division of Hematology-Oncology, Miami, FL
Description
This text bridges the gap between hematology and oncology, offering practical clinical guidance for every phase of patient management
from diagnosis to outcomes assessment. A wealth of tables, boxes, and algorithms provide at-a-glance access to key information and tips
from the experts.
Audience
Hematologists, Oncologists, Internists, and Oncology Nurses
Contents
I GENERAL
1. Weight loss
2. Fever of unknown origin
3. Pruritus
Head
4. Headache
5.
Seizures
6. Crainal neuropathy
7. Encephalopathy and neuropathy
Neck
8. Neck mass
9. Hoarseness
Breast
10.
Palpable mass
11. Abnormal mammogram
12. Nipple discharge
Pulmonary
13. Dyspnea
14. Pulmonary Nodules
15.
Pleural effusion
16. Hilar and mediastinal adenopathy
17. Superior Vena Caval Syndrome
18. Hemoptysis
Abdomen
19.
Bowel obstruction
20. Imaging of Focal Liver Lesions
21. Ascites
22. Splenomegaly
23. Dysphagia
24. Gastrointestinal Bleeding
Bone
25. Pathologic Fractures
26. Evaluation of Back Pain
Genito-Urinary
27. Renal and Adrenal masses
28.
Hematuria
29. Testicular mass
30. Vaginal bleeding
Lymphoid
31. Lymphadenopathy
Blood
chemistry abnormalities
32. Hypercalcemia
33. Elevated bilirubin
34. Immunoglobulin abnormalities
35. Iron Studies
Hematological
Abnormalities
36. Thrombocytosis and Thrombocytopenia
37. Anemia
38. Quantitative abnormalities of leukocytes
39.
Pancytopenia
40. Erythrocytosis
41. Bleeding disorders
42. Morphologic Abnormalities of the Peripheral Blood Smear
43. Venous
thromboembolic disease
Skin
44. Cutaneous manifestations of bleeding
45. Pigmented skin lesions
Cancer
of unknown primary
46. Cancer of unknown primary
II. THERAPEUTIC PRINCIPLES
47. Radiation oncology
48.
Chemotherapy
49. Biologic therapy
50. Bone marrow transplantation
51. Growth factors
52. Transfusion medicine
III.
EVALUATION AND TREATMENT OF HEMATOLOGIC AND ONCOLOGIC DISEASE
Hematologic Disorders
53. Stem cell disorders
54.
Red cells disorders
55. White cells disorders
56. Platelets: Acquired and congenital disorders
57. Coagulation disorders-Acquired
and congenital/DIC
58. Thromboembolic disorders
Hematologic Malignancies
59. Acute Myeloid Leukemia
60.
Acute Lymphocytic Leukemia
61. Myelodysplasia
62. Multiple Myeloma/Macroglobulinema/Amyloidosis
63. Non-Hodgkin's Lymphoma
64.
Hodgkin's Disease
65. Low-grade non-Hodgkin's lymphoma
66. Intermediate and High-Grade Non-Hodgkin's Lymphoma
67. Extranodal
non-Hodgkin's Lymphoma
68. Peripheral T-cell non-Hodgkin's Lymphoma
69. Adult T-cell leukemia's/HTLV I
70. Chronic Myeloid Leukemia
71.
Chronic Lymphocytic Leukemia and Hairy Cell Leukemia
72. Myeloid Metaplasia and Myelofibrosis, Polycythemia Vera, and Essential Thrombocythemia
Breast
Cancer
73. Staging, prognostic factors
74. Non-invasive breast cancer
75. Locally invasive disease
76. Metastatic
breast cancer
77. Supportive measures
Gynecologic Cancer
78. Cervical/vulvo-vaginal
79. Uterine/endometrial
80.
Ovarian
81. Trophoblastic
Genitourinary Cancer
82. Testicular Cancer
83. Renal cell carcinoma
84.
Bladder Cancer – Superficial
85. Bladder Cancer – Muscle-Invasive
86. Prostate Cancer: Screening, staging, management
Gastrointestinal
Cancer
87. Esophageal cancer
88. Gastric cancer
89. Hepatobiliary cancers
90. Pancreatic cancer
91. Colorectal
cancer
92. Anal cancer
Thoracic Cancer
93. Small cell lung cancer
94. Non-small cell lung cancer
95.
Thymoma
96. Mesothelioma
Head and Neck Cancer
97. Secondary Tumors of the Head and Neck: Prognosis, staging,
chemoprevention
98. Squamous cell carcinoma
99. Salivary carcinoma
Sarcoma
100. Bone sarcomas
101.
Soft tissue sarcomas
Neuro-oncology
102. Primary Brain Tumor
103. Brain Metastases
104. Epidural Tumors
and Spinal Cord
Compression
Cutaneous Malignancies
105. Melanoma
106. Non-melanoma
Endocrine
Cancer
107. Thyroid
108. Adrenal
109. Neuroendocrine
110. Pituitary
Cancer of Unknown Primary
111.
Evaluation of cancer of unknown primary
Cancer and the Immunocompromised Host
112. Cancer and the immunocompromised
host
113. Hematologic manifestations of cancer
114. Febrile neutropenia
115. Thromboembolic complications
116. Screening
and genetics counseling for
The cancer patient
117. Unorthodox approaches to cancer therapy
118. Psychosocial issues
119.
Sexual dysfunction
120. Symptom management
121. Tumor Iysis syndrome
| Bibliographic details |
Hardbound, 1312 pages, publication date: JUL-2003
ISBN-13: 978-0-443-06556-9
ISBN-10: 0-443-06556-X
Imprint: CHURCHILL LIVINGSTONE
|
042/413
Last update: 30 Nov 2009
|
|
| |
| | |
|
|
| |
Home | Elsevier Sites | Privacy Policy | Terms and Conditions | Feedback | Site Map | A Reed Elsevier Company